We are live on ! Find out more
ICUI icon

ICU Medical

220 hedge funds and large institutions have $2.66B invested in ICU Medical in 2023 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 72 increasing their positions, 80 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more call options, than puts

Call options by funds: $2.88M | Put options by funds: $2.67M

0.06% less ownership

Funds ownership: 92.47%92.41% (-0.06%)

5% less funds holding

Funds holding: 231220 (-11)

10% less repeat investments, than reductions

Existing positions increased: 72 | Existing positions reduced: 80

25% less first-time investments, than exits

New positions opened: 30 | Existing positions closed: 40

33% less capital invested

Capital invested by funds: $3.96B → $2.66B (-$1.31B)

Holders
220
Holders Change
-11
Holders Change %
-4.76%
% of All Funds
3.49%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
30
Increased
72
Reduced
80
Closed
40
Calls
$2.88M
Puts
$2.67M
Net Calls
+$215K
Net Calls Change
-$22.3M
Name Holding Trade Value Shares
Change
Change in
Stake
Charles Schwab
26
Charles Schwab
California
$20.1M +$1.7M +11,364 +7%
Northwestern Mutual Wealth Management
27
Northwestern Mutual Wealth Management
Wisconsin
$18.2M +$1.81M +12,116 +9%
NC
28
Nitorum Capital
New York
$17.1M +$2.94M +19,700 +16%
Norges Bank
29
Norges Bank
Norway
$16.8M -$7.36M -49,329 -26%
TD Asset Management
30
TD Asset Management
Ontario, Canada
$15.8M -$149K -1,000 -0.7%
Federated Hermes
31
Federated Hermes
Pennsylvania
$15M +$1.15M +7,675 +6%
PCP
32
Pacific Capital Partners
$14.6M +$18.3M +122,500 New
American Century Companies
33
American Century Companies
Missouri
$14M +$331K +2,217 +2%
EA
34
Emerald Advisers
Pennsylvania
$14M +$211K +1,414 +1%
EMFAT
35
Emerald Mutual Fund Advisers Trust
Pennsylvania
$11.7M +$1.25M +8,410 +9%
New York State Common Retirement Fund
36
New York State Common Retirement Fund
New York
$9.57M -$92.5K -620 -0.8%
Allspring Global Investments
37
Allspring Global Investments
North Carolina
$9.36M -$36.5M -244,427 -76%
Principal Financial Group
38
Principal Financial Group
Iowa
$9.27M -$146K -977 -1%
Empower Advisory Group
39
Empower Advisory Group
Colorado
$8.59M +$826K +5,534 +8%
GF
40
Gabelli Funds
New York
$8.57M
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$7.41M -$72.1K -483 -0.8%
EAM
42
Eagle Asset Management
Florida
$7.33M -$317K -2,125 -3%
WHG
43
Westwood Holdings Group
Texas
$6.44M +$2.7M +18,084 +50%
WP
44
Woodline Partners
California
$5.91M -$6.43M -43,104 -46%
Fisher Asset Management
45
Fisher Asset Management
Washington
$5.83M
T. Rowe Price Associates
46
T. Rowe Price Associates
Maryland
$5.76M -$15.5M -104,096 -68%
Swiss National Bank
47
Swiss National Bank
Switzerland
$5.36M +$74.6K +500 +1%
N
48
Nuveen
North Carolina
$5.35M -$1.89M -12,656 -22%
Invesco
49
Invesco
Georgia
$5.29M -$34.3K -230 -0.5%
SI
50
Scout Investments
Missouri
$5.02M -$183K -1,227 -3%

ICUI Hedge Fund Activity: Q3 2023 in Review

220 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in ICU Medical (ICUI) for Q3 2023, worth a combined $2.66B — down 33% from $3.96B a quarter earlier.

Sellers outnumbered buyers: 40 funds closed out of ICUI and 30 opened new positions — a net loss of 10 holders — while 80 trimmed existing stakes and 72 added.

The largest buyer was Fidelity Investments, adding an estimated $79.5M. The largest seller was Wellington Management Group, cutting an estimated $61.6M.

  • 220 institutional investors held ICU Medical (ICUI) as of Q3 2023, down from 231 in Q2 2023.
  • Funds reported $2.66B of ICU Medical stock for Q3 2023, down 33% quarter-over-quarter.
  • 30 funds opened new ICU Medical positions in Q3 2023 and 40 closed out, a net change of -10 holders.
  • The largest ICU Medical buyer in Q3 2023 was Fidelity Investments, an estimated $79.5M added.
  • The largest ICU Medical seller in Q3 2023 was Wellington Management Group, an estimated $61.6M sold.

Based on aggregated 13F filings for Q3 2023.